Canopy Growth Corp - 10-Q Filing
Canopy Growth Corp reports Q2 fiscal 2026 results featuring revenue from Canadian medical and adult-use cannabis segments and updates on convertible debenture exchange transactions.
Tickers: $CGC
Read the full article at SEC EDGAR
Part of the story Adaptive Biotechnologies Corp - 10-Q Filing (3 articles)